D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limb

⚠ Non-Billable ICD-10-CM 2026
Open D17.2 in the app →

Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for D17.2.

The ICD-10-CM code for Benign lipomatous neoplasm of skin and subcutaneous tissue of limb is D17.2 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
D10-D36: Benign neoplasms, except benign neuroendocrine tumors (D10-D36)
Category D17
20 codes (16 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D17.2:

  • Lipoma › site classification › legs (skin) (subcutaneous)
  • Lipoma › site classification › arms (skin) (subcutaneous)

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Cite This Page

Reference D17.2 with the canonical source and edition:

D17.2 — Benign lipomatous neoplasm of skin and subcutaneous tissue of limb. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/D17.2

Canonical URL: https://icd10codingpro.com/codes/D17.2

Related Codes

Parent Code

D17 Benign lipomatous neoplasm

More Specific Codes

Related Codes in D17

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial